With the advent of multidrug-resistant Mycobacterium tuberculosis strains,
new and effective therapies are rapidly needed to combat infections caused
by these strains. Some new 2-quinoxalinecarbonitrile 1,4-di-N-oxides have b
een synthesized and tested as antituberculosis agents and interesting resul
ts have been obtained from the first screening.